» Articles » PMID: 28360837

New Insights into the Crosstalk Between NMDARs and Iron: Implications for Understanding Pathology of Neurological Diseases

Overview
Specialty Molecular Biology
Date 2017 Apr 1
PMID 28360837
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Both iron dyshomeostasis and N-methyl-D-aspartate receptors (NMDARs)-mediated neurotoxicity have been shown to have an important role in neurological diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD). Evidence proved that activation of NMDARs could promote iron overload and iron-induced neurotoxicity by enhancing iron importer divalent metal transporter 1 (DMT1)-mediated iron uptake and iron releasing from lysosome. Also, iron overload could regulate NMDARs-mediated synaptic transmission. This indicates that there might be a possible relationship between iron and activation of NMDARs in neurological diseases. Understanding this interaction between iron and activation of NMDARs may provide new therapeutic avenues for a more targeted neurotherapeutic strategy for these diseases. Therefore, in this review article, we will describe the dysfunction of iron metabolism and NMDARs in neurological diseases including PD and AD, and summarize the new insight into the mechanisms underlying the interaction between iron and activation of NMDARs.

Citing Articles

The role of protein phosphorylation modifications mediated by iron metabolism regulatory networks in the pathogenesis of Alzheimer's disease.

Liu F, Yang S, Shi K, Li D, Song J, Sun L Front Aging Neurosci. 2025; 17:1540019.

PMID: 40071123 PMC: 11893871. DOI: 10.3389/fnagi.2025.1540019.


Regional brain iron correlates with transcriptional and cellular signatures in Alzheimer's disease.

Yang A, Luan J, Xu M, Du L, Lv K, Hu P Alzheimers Dement. 2025; 21(1):e14459.

PMID: 39876820 PMC: 11775454. DOI: 10.1002/alz.14459.


Perturbed iron biology in the prefrontal cortex of people with schizophrenia.

Lotan A, Luza S, Opazo C, Ayton S, Lane D, Mancuso S Mol Psychiatry. 2023; 28(5):2058-2070.

PMID: 36750734 PMC: 10575779. DOI: 10.1038/s41380-023-01979-3.


Ferroptosis is involved in regulating perioperative neurocognitive disorders: emerging perspectives.

Song Y, Wu Z, Xue H, Zhao P J Neuroinflammation. 2022; 19(1):219.

PMID: 36068571 PMC: 9450301. DOI: 10.1186/s12974-022-02570-3.


Rare Gain-of-Function Variant Associated with Cerebellar Ataxia, Parkinsonism, Cognitive Dysfunction, and Brain Iron Accumulation.

Hsiao C, Tropea T, Fu S, Bardakjian T, Gonzalez-Alegre P, Soong B Int J Mol Sci. 2021; 22(15).

PMID: 34361012 PMC: 8347726. DOI: 10.3390/ijms22158247.


References
1.
Altamura S, Muckenthaler M . Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimers Dis. 2009; 16(4):879-95. DOI: 10.3233/JAD-2009-1010. View

2.
Schiemann J, Schlaudraff F, Klose V, Bingmer M, Seino S, Magill P . K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration. Nat Neurosci. 2012; 15(9):1272-80. PMC: 4242970. DOI: 10.1038/nn.3185. View

3.
Carvajal F, Mattison H, Cerpa W . Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies. Neural Plast. 2016; 2016:2701526. PMC: 5007376. DOI: 10.1155/2016/2701526. View

4.
Zhang S, Wang J, Song N, Xie J, Jiang H . Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. Neurobiol Aging. 2008; 30(9):1466-76. DOI: 10.1016/j.neurobiolaging.2007.11.025. View

5.
Bading H . Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations. J Exp Med. 2017; 214(3):569-578. PMC: 5339681. DOI: 10.1084/jem.20161673. View